Having met the milestones of the R61, this R33 is a 2-site, 2-group, pre/post RCT of mothers with OUD (n=\~80/group). We will test whether the beneficial pre-post changes in OUD mothers randomized to vMP exceed those of mothers assigned to Enhanced Usual Care (EUC) and via changes in Maternal Brain Neurocircuits.
Age range
18 Years – 50 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Clinical trial enrollment counts.
Timeframe: 3 years
Mom Power (MP) Intervention vs. Enhanced Usual Care (EUC) session counts.
Timeframe: 3 years
Electroencephalography (EEG) Brain Imaging scans counts.
Timeframe: 3 years
Functional Magnetic Resonance Imagine (fMRI) Brain Imaging counts before and after MP and EUC.
Timeframe: 3 years
Treatment-related changes in mood as assessed by the Edinburgh Postnatal Depression Scale (EPDS).
Timeframe: 3 years
Treatment-related changes in anxiety as assessed by PTSD Checklist for DSM-5 (PCL-5).
Timeframe: 3 years
Treatment-related changes in stress as assessed by the Parenting Stress Index (PSI).
Timeframe: 3 years
Treatment-related changes in drug craving as assessed by the Opioid Craving Scale (OCS).
Timeframe: 3 years
Treatment-related changes in N170 and late positive potential (LPP) measures as assessed by Electroencephalography (EEG).
Timeframe: 3 years
Treatment-related changes in brain activity assessed by functional magnetic resonance imaging (fMRI).
Timeframe: 3 years